Netherlands· NL-b51354eed6a9

Lambipol 25 mg, kauwtabletten/dispergeerbare tabletten

A lamotrigine product containing lamotrigine, registered in Netherlands by GlaxoSmithKline B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC N03AX09

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about lamotrigineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Lamotrigine is registered in 18 of 19 countries.

Countries holding a registration under ATC N03AX09 (lamotrigine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search lamotrigine products by name

Lamotrigine · ATC N03AX09

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lamotrigine costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.14 in United States to $4.21 in Switzerland — a ×30 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Lamotrigine · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

CH Switzerland$4.21
IT Italy$2.00
FR France$1.69
US United States$0.14 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LAMOTRIGINE
Manufacturer: GlaxoSmithKline B.V.
Country: Netherlands (NL)
ATC code: N03AX09
ATC class: Lamotrigine
Defined daily dose: 0.3 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
107451

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

248 interactions on record for lamotrigine.

Graded by severity as the source publishes them — 68 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check lamotrigine against other medicines How interaction checks work

Lamotrigine · interactions on record

248 records

68 moderate
9 minor
129 info

Most severe, free to view

MetoclopramideA03FA01moderate
DiphenhydraminA04AB05moderate
DronabinolA04AD10moderate
NabiloneA04AD11moderate

42 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lamotrigine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lamotrigine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Gerolamic, Lamictal
Belgium · Lambipol, Lamictal
Bulgaria · Епитрижин, Ламиктал
Cyprus · Lamictal, Lamosynt
Czechia · Lamictal, Lamotrigin Actavis
Germany · Lamictal, Lamotrigin 1 A Pharma
Denmark · Lamictal, Lamotrigin
Estonia · Lamictal, Lamotrigine Desitin
Spain · Crisomet, Labileno
Finland · Lamictal, Lamotrigin Desitin
France · Lamictal, Lamotrigine
United Kingdom (Northern Ireland) · Lamictal, Lamotrigine
Greece · Dezepil, Lamictal
Croatia · Arvind, Lamal
Hungary · Gerolamic, Lamictal
Ireland · Lamictal, Lamotrigine Desitin
Iceland · Lamictal
Italy · Amaless, Lamictal
Lithuania · Lamictal
Luxembourg · Lambipol, Lamictal
Latvia · Lamictal, Lamotrix
Malta · Lamictal, Lamotrigine Aurobindo
Norway · Lamictal, Lamotrigin Desitin
Poland · Epitrigine, Lamilept
Portugal · Lamictal, Lamotrigina Accord
Romania · Lamictal, Lamotrix
Sweden · Lamictal, Lamotrigin
Slovenia · Lamal, Lamictal
Slovakia · Lamictal, Lamotrigin Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/a4620d7a-9dbe-45fc-bf64-3f5f8dd2f0ce
GET /v1/drugs/a4620d7a-9dbe-45fc-bf64-3f5f8dd2f0ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kauwtablet, Dispergeerbare tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h107451_smpc.pdf",
  "strength": null,
  "atc_label": "Lamotrigine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg107451",
  "excipients": [
    "ALUMINIUMMAGNESIUMSILICAAT",
    "CALCIUMCARBONAAT (E 170)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 30 (E 1201)",
    "SACCHAROIDE NATRIUM X-WATER (E 954)",
    "ZWARTE BESSEN SMAAKSTOF 502.009 / AP 0551"
  ],
  "substances": [
    "LAMOTRIGINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h107451.pdf",
  "authorised_at": "2010/06/07",
  "procedure_number": "NL/H/2051/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "107451",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about lamotrigine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console